Explore chapters and articles related to this topic
Organizational Factors of Patient Safety and Handover in a General Hospital
Published in Teuku Tahlil, Hajjul Kamil, Asniar, Marthoenis, Challenges in Nursing Education and Research, 2020
Henki Adisa Putra, Endang Mutiawati R, Hajjul Kamil
This type of research is quantitative with cross sectional study design. The study population are all nurses in the Inpatient ward of a General Hospital with amount of 173 people, the sample size used total sampling method. Instrument to measure organizational factors about patient safety used was the Hospital Survey on Patient Safety from the Agency for Healthcare Research and Quality (AHRQ) U.S. Department of Health and Human Services. The instrument to measure nurse’s handover was carried out using instruments developed by Arini. Data were analyzed by chi-square test and binary logistic regression with the stepwise method.
Research in Psychology
Published in Mohamed Ahmed Abd El-Hay, Understanding Psychology for Medicine and Nursing, 2019
The defining feature of a cross-sectional study is that it compares different population groups at a single point of time. A cross-sectional study involves assessment, at the same time, of people who are similar on some characteristics but different on a key factor of interest such as age, income levels, or geographic locations. Participants are usually separated into groups known as cohorts, e.g., researchers might create cohorts of participants who are in their twenties, thirties, and forties. The benefit of a cross-sectional study design is that it allows researchers to compare many different variables at the same time, e.g., comparison of age, gender, income, and educational level in relation to a personality trait.
Rare Diseases Drug Development
Published in Shein-Chung Chow, Innovative Statistics in Regulatory Science, 2019
In practice, natural history studies could be conducted either prospectively or retrospectively (e.g., based on existing medical records such as patient charts). Data could be collected from cohorts of patients under either a cross-sectional study or a longitudinal study. As indicated by the FDA, for a prospective design, a cross-sectional study may be conducted more quickly than a longitudinal study. However, cross-sectional studies are unable to provide a comprehensive description of the course of progressive or recurrent diseases (FDA, 2019).
A systematic review and meta-analysis of the correlation between polycystic ovary syndrome and irritable bowel syndrome
Published in Gynecological Endocrinology, 2023
Zhaokang Wei, Zuhui Chen, Wenle Xiao, Gangjie Wu
Table 1 provides a summary of the included studies in this meta-analysis. The included articles were published from 2010 to 2022 and carried out in various countries (Iran, United States, China, Turkey, Poland, and Saudi Arabia) with sample sizes ranging between 65 and 690. IBS prevalence in PCOS patients was revealed in four studies. One study indicated exacerbating IBS-related sleep and psychiatric disorders risk in obese women with PCOS, and another investigated influence of IBS in PCOS patients on the quality of life. Among six studies, four were case-control studies, one was a cross-sectional study, and one was a case-control and cross-sectional study. Moreover, four studies used the Rotterdam criteria, one employed the National Institutes of Health (NIH) criteria, and one used patients’ medical data for PCOS diagnosis. IBS diagnosis was based on the Roma I criteria [23] (n = 1), Roma III criteria [23] (n = 3), Roma IV criteria [23] (n = 1), and Rome IV diagnostic questionnaire (n = 1). Finally, 5 articles with 755 women with PCOS and 513 healthy controls were included in the meta-analysis.
Parents Talking to Middle School Children about Sex: A Protective Factor against Suicide in Sexually Active Teens
Published in American Journal of Sexuality Education, 2023
Monica St. George, Danielle R. M. Niemela, Robert J. Zeglin
The results of this study should only be considered in light of the study’s limitations. First, the sample was drawn from only one county in the urban coastal southeast United States. This may limit its generalizability to other, particularly more rural, populations. Also, the study instrument only offered “male” and “female” as gender identity options and did not ask about sexual orientation at all. This severely limits the study’s ability to assess whether the identified significant associations differ for sexual and gender minority adolescents, a growing cohort of young adults (Laughlin, 2016; White et al., 2018). A third limitation, one inherent in a non-experimental cross-sectional study, is the lack of causal inference that can be made based on the study’s results. Finally, the study instrument did not ask about the quality or reception of the parent’s conversation about sex. Young adults with varying levels of sexual knowledge, comfort, and values or those with stronger or weaker relationships with their parents may have experienced the conversation about sex markedly differently. Similarly, knowing whether the child or the parent initiated the conversation about sex could prove to be a significant moderator in the relationship between conversations about sex and suicidality. Other examples of possible mediating or moderating variables are perceived parental limit-setting and timing of conversation relative to sexual debut. The present study was not able to assess for such differences in these and similar variables. Despite these limitations, the present study was able to answer its guiding research question.
Gender differences in the associations of multiple psychiatric and chronic conditions with major depressive disorder among patients with opioid use disorder
Published in Journal of Addictive Diseases, 2022
Christian Nwabueze,, Hilary Elom,, Sophia Liu,, Suzy Mascaro Walter,, Zhanxin Sha,, Priscila Acevedo,, Ying Liu,, Brenda Bin Su,, Chun Xu,, Ubolrat Piamjariyakul,, Kesheng Wang,
This is a cross-sectional study using secondary data analysis. The data was from the Project Starting Treatment with Agonist Replacement Therapies (START) that was conducted by the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) (CTN-0027). The primary objective of the START study was to compare changes in liver enzymes related to the treatment of OUD patients with buprenorphine/naloxone compared to methadone, and details about the data are described elsewhere.14,15 A total of 1,920 participants were screened. After we merged the data, there were 1,646 unique participants. The START study was approved by the institutional review boards at participating sites, and participants provided written informed consent.14,15 There was an Institutional Review Board exemption for the present study due to secondary data analysis using a publicly accessible database.